Yang JC - Search Results

1

Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens.

Ma WL, Lin CC, Hsu FM, Lee JM, Chen JS, Huang YL, Chang YL, Chang CH, Yang JC. Ma WL, et al. Among authors: yang jc. Cancer Med. 2022 Sep;11(18):3445-3456. doi: 10.1002/cam4.4711. Epub 2022 Mar 29. Cancer Med. 2022. PMID: 35348307 Free PMC article.

2

Optimal management of patients with non-small cell lung cancer and epidermal growth factor receptor mutations.

Lin CC, Yang JC. Lin CC, et al. Among authors: yang jc. Drugs. 2011 Jan 1;71(1):79-88. doi: 10.2165/11587560-000000000-00000. Drugs. 2011. PMID: 21175241 Review.

3

Polo-like kinase 1 inhibitors and their potential role in anticancer therapy, with a focus on NSCLC.

Medema RH, Lin CC, Yang JC. Medema RH, et al. Among authors: yang jc. Clin Cancer Res. 2011 Oct 15;17(20):6459-66. doi: 10.1158/1078-0432.CCR-11-0541. Clin Cancer Res. 2011. PMID: 22003073 Review.

4

Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR.

Chung KP, Wu SG, Wu JY, Yang JC, Yu CJ, Wei PF, Shih JY, Yang PC. Chung KP, et al. Among authors: yang pc, yang jc. Clin Cancer Res. 2012 Jun 15;18(12):3470-7. doi: 10.1158/1078-0432.CCR-11-2353. Epub 2012 Apr 17. Clin Cancer Res. 2012. PMID: 22510346

5

Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.

Liao WY, Chen JH, Wu M, Shih JY, Chen KY, Ho CC, Yang JC, Yu CJ. Liao WY, et al. Among authors: yang jc. Clin Lung Cancer. 2013 Jul;14(4):418-24. doi: 10.1016/j.cllc.2012.10.003. Epub 2013 Jan 4. Clin Lung Cancer. 2013. PMID: 23291258

6

First-line management of EGFR-mutated advanced lung adenocarcinoma: recent developments.

Liao BC, Lin CC, Yang JC. Liao BC, et al. Among authors: yang jc. Drugs. 2013 Mar;73(4):357-69. doi: 10.1007/s40265-013-0020-8. Drugs. 2013. PMID: 23479407 Review.

7

EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer.

Kao HF, Lin CC, Yang JC. Kao HF, et al. Among authors: yang jc. Future Oncol. 2013 Jul;9(7):991-1003. doi: 10.2217/fon.13.56. Future Oncol. 2013. PMID: 23837762 Review.

8

First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: a randomised, phase 3 trial.

Yang JC, Kang JH, Mok T, Ahn MJ, Srimuninnimit V, Lin CC, Kim DW, Tsai CM, Barraclough H, Altug S, Orlando M, Park K. Yang JC, et al. Eur J Cancer. 2014 Sep;50(13):2219-30. doi: 10.1016/j.ejca.2014.05.011. Epub 2014 Jun 18. Eur J Cancer. 2014. PMID: 24953333 Clinical Trial.

9

Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer.

Lee JH, Lin YL, Hsu WH, Chen HY, Chang YC, Yu CJ, Shih JY, Lin CC, Chen KY, Ho CC, Laio WY, Yang PC, Yang JC. Lee JH, et al. Among authors: yang pc, yang jc. J Thorac Oncol. 2014 Sep;9(9):1385-92. doi: 10.1097/JTO.0000000000000238. J Thorac Oncol. 2014. PMID: 25057939 Free article.

10

Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.

Chen YF, Hsieh MS, Wu SG, Chang YL, Shih JY, Liu YN, Tsai MF, Tsai TH, Yu CJ, Yang JC, Yang PC. Chen YF, et al. Among authors: yang pc, yang jc. J Thorac Oncol. 2014 Aug;9(8):1171-9. doi: 10.1097/JTO.0000000000000232. J Thorac Oncol. 2014. PMID: 25157770 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,724 results

Search Page